echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Another listed company divested hospital assets to exit the medical industry!

    Another listed company divested hospital assets to exit the medical industry!

    • Last Update: 2021-01-23
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Pharmaceutical Network January 20, listed companies divested hospital assets according to the "look at the medical community" understand, January 18, listed companies Changbao shares issued a notice, according to the company's strategic development needs, in order to further effectively integrate resources, optimize the asset structure, continue to promote the implementation of the previous plan to withdraw from the medical service industry related matters, the implementation of the main energy pipe industry focus.
    will sell its 100% stake in Shandong Ruigao, 100% stake in Shishan Second Hospital and 90% stake in Yuyanghe People's Hospital to Zhongmin Jiaye and Shanghai Jiahe Medical.
    January 17, the company has signed a "hospital equity purchase agreement" with Zhongmin Jiaye and Jiahe Medical.
    it is reported that Shandong Ruigao's main assets are 71.23 percent of the shares held in Dongda Hospital in Shanxian County, with total assets of about 611 million yuan (as of September 30, 2020), revenue of 201 million yuan in January-September 2020 and net profit of 11.25 million yuan.
    Public information shows that single county Dongda Hospital, Shandong Single County, the second-level A general hospital, was established in 2014, covers an area of 220 acres, construction area of 47,000 square meters, with 660 employees, 600 beds, 300,000 annual outpatients, 26,000 inpatients.
    total assets of the second hospital were about 238 million yuan (as of September 30, 2020), and revenue for the January-September 2020 period was RMB99.35 million, with a net profit of RMB14.16 million.
    the hospital is a second-class A-level general hospital in Shifang City, Sichuan Province, covering an area of more than 30 acres, 600 beds, 200,000 annual outpatient visits, more than 15,000 inpatients.
    total assets of the Yanghe People's Hospital in Shanghai (as of September 30, 2020), revenue of 73.39 million yuan and net profit of 14.89 million yuan for the period From January to September 2020.
    according to the official website of the hospital, Yanghe People's Hospital in Cebu City is built in accordance with the standards of the three-level general hospital, covering a total area of about 120 acres, construction area of about 120,000 square meters, planning 1200 beds, the first phase of the opening of 600 beds.
    according to the 2020 semi-annual report, Changbao shares of the main business for metal products, medical services, accounting for 86.9% of revenue, 13.1%, respectively.
    it is understood that as early as 2016, Changbao shares began planning cross-border transformation of the medical services industry, in 2017, Changbao shares spent 992 million yuan to acquire medical assets, and then less than two years later, it intends to gradually withdraw from the medical services industry.
    time, Changbao shares announced that "compared to the medical services industry, the company invested in the development of energy pipe sector, more control experience and development advantages."
    health care industry is also more vulnerable to industry policies, there is uncertainty in the company's response.
    " according to the announcement, took over the hospital assets of Jiayu Medical as Changbao shares of the second largest shareholder, while the other trading party Zhongmin Jiaye is the controlling shareholder of Jiayu Medical, and Jiayu Medical has a concerted action relationship, the two take-over companies are related to Changbao shares, so the transaction constitutes a related transaction.
    several listed companies sold hospital public information shows that in recent years, due to the intensive introduction of a number of national policies to encourage social health care, public hospital restructuring, real estate, retail and other companies have joined the investment capital, set off a wave of hospital investment and mergers and acquisitions.
    the smell-sensitive major capital into the medical field, real estate, tea, tiles, coal, pearl farming and other listed companies have poured in, triggering the hospital investment in the craziest three years.
    , however, in recent years, listed companies have experienced a rush to exit the "roller coaster".
    but as capital retreated, a wave of hospital selling began.
    December 15, 2020, Xinhua Medical announced that it intends to sell its 70% stake in the West Hospital of Zibo Yuchuan District Hospital by public listing through the Property Rights Trading Center.
    2020, Shandong Business Daily reported that 80% of the shares of Nanyang Orthopaedic High-technology District Hospital Co., Ltd., owned by Xinhua Medical, had been transferred.
    in the past two decades of development process, Xinhua Medical has repeatedly made large acquisitions of hospitals.
    To orthopaedics as an example, in recent years, Xinhua Medical has invested in Changguo Hospital, Pingyin County Chinese Medicine Hospital, Nanyang Orthopaedic Hospital, Hefei Southeast Orthopaedic Hospital and Hefei Southeast Hand Surgery Hospital.
    2015, Xinhua Medical began touting hospital-related assets after years of extended expansion.
    In addition to the frequent sell-off of hospitals by Xinhua Hospital, in early December 2020, ST Hengkang also issued a notice that, in order to ease the company's capital pressure and supplement the company's liquidity, the company held a board of directors on December 1 to consider and agree to the transfer of its holding of Dalian Liaoyu Hospital 100% of the investor's equity and all related interests.
    understood that in the recent sell-off of hospitals listed enterprises, there is no shortage of poor management, losses and give up.
    some companies are selling off hospitals that are still profitable.
    listed companies sell off after a passion for healthcare investment? Zhuang Yiqiang, deputy secretary-general of the China Hospital Association, believes that this may be because these cross-border enterprises are under-assessing the real complexity of medical investment.
    in the healthcare industry is unique - large capital, long payback cycles, but not easily affected by the economic cycle.
    industry experts say factors such as slow fund withdrawals, the impact on the company's main business, divisions within the company's management, cross-border water and soil frustration, and policy uncertainty have been major setbacks for these listed companies to move into the medical services sector, and some otherwise optimistic "cross-borderers" have begun to reassess the cost of entry.
    experts believe that hospital operations need a longer cycle of market development, resource accumulation and brand building, hospitals are not a short and smooth business.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.